Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

An Improved Murine Femur Fracture Device For Bone Healing Studies, Joseph Marturano, Benjamin Cleveland, Melissa Bryne, Shannon O'Connell, John Wixted, Kristen Billiar Dec 2015

An Improved Murine Femur Fracture Device For Bone Healing Studies, Joseph Marturano, Benjamin Cleveland, Melissa Bryne, Shannon O'Connell, John Wixted, Kristen Billiar

Kristen L. Billiar

Murine models are commonly used to investigate bone healing and test new treatments before human trials. Our objective was to design an improved murine femur fracture device and determine optimal mass and velocity settings for maximal likelihood of transverse fracture. Fracture reproducibility was maximized using an adjustable kinetic energy level, a novel mouse positioning system and an electromagnet striker release assembly. Sixty wild-type mice of 8-12-week-old male and female with a weight of 26.4+/-6.1g were subjected to an experimental postmortem fracture in the left and right femur (n=120) using variable kinetic energy inputs. A best-fit prediction equation for transverse fracture …


Differential Effects Of Egf And Tgf-Beta1 On Fibroblast Activity In Fibrin-Based Tissue Equivalents, Jaime Grouf, Angela Throm, Jenna Balestrini, Katie Bush, Kristen Billiar Dec 2015

Differential Effects Of Egf And Tgf-Beta1 On Fibroblast Activity In Fibrin-Based Tissue Equivalents, Jaime Grouf, Angela Throm, Jenna Balestrini, Katie Bush, Kristen Billiar

Kristen L. Billiar

Transforming growth factor-beta1 (TGF-beta1) is commonly used to promote matrix production for engineered tissues in vitro, yet it also enhances fibroblast contractility. For applications where contraction is undesirable, we hypothesized that epidermal growth factor (EGF) would yield equivalent mechanical properties without enhancing contractility. In this study, the response of human dermal fibroblasts to EGF (5 ng/mL) and TGF-beta1 (5 ng/mL) was determined within hemispheric fibrin-based gels by assessing matrix compaction and strength, cell number, collagen production, and contractility. After 3 weeks, both cytokines enhanced compaction relative to controls, and EGF roughly doubled matrix strength over controls and TGF-beta1-treated samples. TGF-beta1 …